Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ACET - ASCO Annual Meeting 2022: An Innovation Showcase In Cancer Treatment

ACET - ASCO Annual Meeting 2022: An Innovation Showcase In Cancer Treatment

Adicet Bio Inc.
  • At the ASCO meeting, BioNTech presented phase-1 clinical trial data for its mRNA-based vaccine for pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.
  • AstraZeneca and Daiichi presented data for the Destiny-Breast04 trial, which tested Enhertu against chemotherapy in HER2-low patients.
  • Arcellx, a CAR-T biotechnology firm, presented encouraging phase 1 data for their multiple myeloma CAR-T therapy.
  • Adicet Bio presented phase 1 clinical trial data for its allogeneic CAR-T therapy, ADI-001, in a common form of lymphoma.

For further details see:

ASCO Annual Meeting 2022: An Innovation Showcase In Cancer Treatment
Stock Information
Company Name: Adicet Bio Inc.
Stock Symbol: ACET
Market: NASDAQ
Website: adicetbio.com
Menu
ACET ACET Quote ACET Short ACET News ACET Articles ACET Message Board
Get ACET Alerts

News, Short Squeeze, Breakout and More Instantly...